Outside of covid-19 diagnostics: Nine out of 16 APAC IVD markets have recovered to pre-pandemic levels Asia-Pacific (APAC) IVD markets have grown and exceeded… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Tissue Diagnostics (TDx) | Asia | Centralised Diagnostics (CEDx) | Covid-19 testing | Infectious Diseases Testing Monitor | IVD Gateway | Molecular Diagnostics (MDx)
The fastest-growing areas for APAC’s next-generation sequencing market The next-generation sequencing (NGS) market is expected to… In-vitro diagnostics | Next Generation Sequencing (NGS) | Asia | IVD Gateway | Next Generation Sequencing (NGS)
TAVR Japan: A third of procedures carried out in small and mid-sized hospitals Transcatheter aortic valve replacements (TAVR) is set to be… Cardiovascular surgery | Minimally invasive surgery | Surgical device | Asia | Cardiovascular Surgery | Minimally invasive surgery | Surgical Gateway
TAVR bioprosthetic heart valve market to grow between 20-25% in east Asia Transcatheter aortic valve replacements (TAVR) is set to be… Cardiovascular surgery | Minimally invasive surgery | Surgical device | Asia | Cardiovascular Surgery | Minimally invasive surgery | Surgical Gateway
Key domestic market players shaping the future of TAVR in China Access to Transcatheter aortic valve replacements (TAVR)… Cardiovascular surgery | Minimally invasive surgery | Surgical device | Asia | Cardiovascular Surgery | Minimally invasive surgery | Surgical Gateway
2022 healthcare megatrends shaping IVD 2022 healthcare megatrends shaping IVD… In-vitro diagnostics | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Point-of-care testing (POCT) | Asia | Europe | Middle East & Africa | IVD Gateway | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Point-of-care testing (POCT)
2022 healthcare megatrends shaping the surgical-device sector This infographic looks at three trends in healthcare that… General surgery | Minimally invasive surgery | Orthopaedic & Spine Surgery | Surgical device | Asia | Europe | Middle East & Africa | Cardiovascular Surgery | Minimally invasive surgery | Orthopaedic & Spine Surgery | Robotic surgery | Surgical Gateway | Urology
Rapid antigen tests to erode PCR-based molecular covid test market in APAC Emergent covid-19 screening technologies coupled with… Covid-19 testing | Molecular Diagnostics (MDx) | Asia | IVD Gateway | Molecular Diagnostics (MDx)
Molecular diagnostics instrument sales in Asia-Pacific set to normalise as vaccination rates rise Molecular diagnostics (MDX) instrument sales in Asia-Pacific… In-vitro diagnostics | Molecular Diagnostics (MDx) | Asia | IVD Gateway | Molecular Diagnostics (MDx)
Covid-19: Molecular testing capacity expands in Asia-Pacific Molecular diagnostics (MDx) testing capacities and… Covid-19 testing | In-vitro diagnostics | Molecular Diagnostics (MDx) | Asia | IVD Gateway | Molecular Diagnostics (MDx)
Trends in minimally invasive cardiovascular surgery in Japan In this infographic, we look at three MIS procedure areas… Cardiovascular surgery | Minimally invasive surgery | Surgical device | Asia | Cardiovascular Surgery | Minimally invasive surgery | Surgical Gateway
Asia surgery boom a key source of opportunities for global medtech companies Surgical procedure volume and the device market is expected… Surgical device | Asia | Surgical Gateway